Recursion Pharmaceuticals Class A financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

리커전 파머슈티컬스NASDAQ:RXRX · Nasdaq · Healthcare · sector #17

$4.63-3.14%

2026-10-06 close

Recursion Pharmaceuticals Class A's published financial data is dated 2026-10-04. 2024 revenue was $59M. 2024 operating profit was −$479M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy